Dr. Eugene Greenberg Digestive Health Institute provides a comprehensive approach to each patient through screenings, medical and surgical therapies, as well as nutritional, social, and other support services. Our specialists focus on taking care of each patient from diagnosis through therapy and treatment. Carle Digestive Health Institute also participates in clinical trials to help further advance medicine and bring tomorrow's cures to today's patients.
Screening is the process of looking for cancer or pre-cancer in people who have no symptoms of the disease. Regular colorectal cancer screening is one of the most powerful tools against colorectal cancer. The American Cancer Society recommends that people at average risk* of colorectal cancer start regular screening at age 45. When colorectal cancer is found at an early stage before it has spread, the 5-year relative survival rate is about 90%. Several tests can be used to screen for colorectal cancer.
The most important thing is to get screened, no matter which test you choose.
*For screening, people are considered to be at average risk if they DO NOT have:
A personal history of colorectal cancer or certain types of polyps
A family history of colorectal cancer
A personal history of inflammatory bowel disease (ulcerative colitis or Crohn’s disease)
A confirmed or suspected hereditary colorectal cancer syndrome, such as familial adenomatous polyposis (FAP) or Lynch syndrome (hereditary non-polyposis colon cancer or HNPCC)
Fecal immunochemical test (FIT)
The fecal immunochemical test (FIT) checks for hidden blood in the stool from the lower intestines. This test must be done every year. It can be done in the privacy of your own home and there are no drug or dietary restrictions before the FIT test is completed. If the test result is positive (that is, if hidden blood is found), a follow-up colonoscopy will need to be done to investigate further. Although blood in the stool can be from cancer or polyps, it can also be from other causes, such as ulcers, hemorrhoids, or other conditions. Reach out to your primary care doctor if you are an average risk patient eligible for an at-home FIT screening. Your health care provider will give you the supplies you need for testing. FIT FAQ's
Cologuard® is a noninvasive screening method that tests for both DNA changes and blood in the stool, it is effective in finding both pre-cancer and cancer. This test should be completed every 3 years. A Cologuard® test can be completed in the privacy of your own home and it does not require you to follow a special diet or change your medications prior to completing the test. Cologuard® does produce some false positive results, so any positive should be discussed with your primary care doctor and followed by a colonoscopy. Cologuard® is prescribed through your health care provider and cannot be purchased over the counter. Reach out to your primary care doctor if you are an average risk patient eligible for an at-home Cologuard® screening. Cologuard FAQ's
A colonoscopy is a diagnostic procedure completed in a hospital or clinic location. For an average risk patient a colonoscopy can be completed every 10 years. This type of screening looks at the inside of the colon and rectum for any abnormal areas that might be cancer or polyps. During a colonoscopy, the doctor looks at the entire length of the colon and rectum with a colonoscope, a flexible tube about the width of a finger with a light and small video camera on the end. It’s put in through the anus and into the rectum and colon. Special instruments can be passed through the colonoscope to biopsy (take a sample) or remove any suspicious-looking areas such as polyps, if needed. It’s important that the colon and rectum are emptied before this test to get the best images, so a colonoscopy requires a bowel prep regimen prior to the appointment. Patients are typically sedated during the procedure, in which case you will need someone to drive you home.
VIDEO - Preparing for your Colonoscopy
For additional information related to colorectal cancer screening options visit the Carle Digestive Health Tools and Instructions page.
Carle colorectal specialists treat conditions that affect the small intestines, colon, rectum and anus, in addition to GI cancers.
Carle Digestive Health experts can help you determine when random discomfort becomes a cause for concern.
With a team approach to care, experts at Carle Cancer Institute develop an individualized plan of treatment for patients with gastrointestinal cancer.
Patients with liver disease can receive specialized care and treatment from expert Carle providers.
The Carle care team will help you manage your Crohn’s disease and ulcerative colitis symptoms and improve your quality of life.
Carle providers offer advanced diagnostic and therapeutic techniques for diseases specific to the pancreas, gallbladder and bile ducts.
Have a patient referral? Refer a patient now.
At Carle, we understand the importance of research and the role research plays in providing quality care to our patients. Research initiatives offer new information about how to combat disease, show new ways of thinking about treatment and possible cures. Carle physicians also partner with scientists at the University of Illinois to study evolving fields in the science of microbiomes, inflammatory bowel disease, C diff, constipation, and other gut related illnesses.
Carle Digestive Health physicians are involved in many ongoing clinical research studies and clinical trials for Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis.
Our skilled physicians are invested in this research to further understand these chronic, sometimes debilitating gastrointestinal (GI) diseases and conditions. To learn more about digestive health research, visit our list of clinical trials or call (844) 37-RESEARCH (844-377-3732) or email us.
The investigators wish to study the effects of three forms of bariatric surgery: gastric bypass, sleeve gastrectomy, and lap banding. The surgery is not part of the clinical trial. If insurance does not cover the procedure, then the patient is responsible for payment of the surgical process. The investigators are doing pre- and post-surgery testing to provide a better understanding of the effect of bariatric surgery-induced weight loss on 1) alcohol absorption, distribution and elimination from the body; 2) the effects of alcohol on blood sugar; and 3) the effects of alcohol on mood.
This multicenter, randomized, double-blinded, placebo-controlled study will evaluate the effect of TU-100 on resolution of postoperative ileus (POI) in subjects undergoing open or laparoscopic bowel resection (BR).
With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.
Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for digestive health patients and their loved ones. With your support, we’ll expand the scope of services offered and further Carle’s dedication to the diagnosis and treatment of digestive issues.
“The person who feels alone because they don’t know anybody else going through what they are going through, those are the people we want to see.”DONATE NOW READ FULL ARTICLE
Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.